UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8757) 8757
Dissertation (60) 60
Newsletter (56) 56
Newspaper Article (54) 54
Publication (39) 39
Magazine Article (19) 19
Book Chapter (14) 14
Conference Proceeding (8) 8
Web Resource (4) 4
Journal / eJournal (2) 2
Paper (2) 2
Book Review (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5264) 5264
life sciences & biomedicine (5082) 5082
losartan (4622) 4622
male (4436) 4436
animals (4129) 4129
humans (3378) 3378
rats (2897) 2897
losartan - pharmacology (2885) 2885
biological and medical sciences (2567) 2567
female (2145) 2145
losartan - therapeutic use (2099) 2099
medical sciences (2067) 2067
angiotensin receptor antagonists (1968) 1968
cardiovascular system & cardiology (1656) 1656
blood pressure - drug effects (1652) 1652
hypertension - drug therapy (1515) 1515
imidazoles - pharmacology (1504) 1504
middle aged (1395) 1395
angiotensin ii (1362) 1362
hypertension (1355) 1355
antihypertensive agents - therapeutic use (1308) 1308
pharmacology & pharmacy (1298) 1298
tetrazoles - pharmacology (1273) 1273
pharmacology. drug treatments (1222) 1222
antihypertensive agents - pharmacology (1171) 1171
rats, sprague-dawley (1153) 1153
angiotensin ii - pharmacology (1152) 1152
angiotensin (1139) 1139
peripheral vascular disease (1132) 1132
cardiovascular system (1083) 1083
biphenyl compounds - pharmacology (1061) 1061
angiotensin ii type 1 receptor blockers - pharmacology (1044) 1044
aged (1008) 1008
adult (933) 933
losartan - administration & dosage (858) 858
rats, wistar (824) 824
cardiac & cardiovascular systems (784) 784
angiotensin ii - antagonists & inhibitors (738) 738
hypertension - physiopathology (738) 738
angiotensin ii - metabolism (733) 733
angiotensin ii type 1 receptor blockers - therapeutic use (714) 714
antihypertensive agents (707) 707
dose-response relationship, drug (686) 686
blood pressure (682) 682
physiology (681) 681
treatment outcome (660) 660
receptor, angiotensin, type 1 (612) 612
fundamental and applied biological sciences. psychology (609) 609
pyridines - pharmacology (606) 606
renin-angiotensin system - drug effects (577) 577
cardiology. vascular system (576) 576
angiotensin-converting enzyme inhibitors - pharmacology (569) 569
angiotensin-converting enzyme inhibitors - therapeutic use (569) 569
time factors (547) 547
mice (531) 531
abridged index medicus (529) 529
disease models, animal (511) 511
drug therapy, combination (503) 503
double-blind method (498) 498
urology & nephrology (484) 484
blood and lymphatic vessels (456) 456
tetrazoles - therapeutic use (451) 451
receptors, angiotensin - metabolism (447) 447
antihypertensive agents - administration & dosage (444) 444
receptor, angiotensin, type 1 - metabolism (434) 434
receptor, angiotensin, type 2 (430) 430
renin-angiotensin system (430) 430
cells, cultured (429) 429
drug therapy (423) 423
kidney - drug effects (405) 405
angiotensin ii - physiology (404) 404
research (404) 404
hypertension - complications (401) 401
rats, inbred shr (397) 397
losartan - adverse effects (396) 396
heart rate - drug effects (382) 382
arterial hypertension. arterial hypotension (375) 375
physiological aspects (374) 374
in vitro techniques (373) 373
renin-angiotensin system - physiology (345) 345
general & internal medicine (340) 340
receptors, angiotensin - physiology (335) 335
analysis (327) 327
endocrinology & metabolism (326) 326
risk factors (325) 325
medicine, general & internal (323) 323
biphenyl compounds - therapeutic use (320) 320
antihypertensive agents - adverse effects (317) 317
hemodynamics - drug effects (306) 306
angiotensin ii type 1 receptor blockers - administration & dosage (294) 294
rodents (294) 294
blood pressure - physiology (293) 293
receptors (288) 288
valsartan (288) 288
biochemistry & molecular biology (286) 286
medicine, research & experimental (279) 279
losartan potassium (275) 275
imidazoles - therapeutic use (274) 274
neurosciences & neurology (273) 273
research & experimental medicine (272) 272
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8505) 8505
Japanese (138) 138
Russian (132) 132
Chinese (129) 129
Portuguese (94) 94
German (92) 92
Spanish (70) 70
French (41) 41
Italian (28) 28
Polish (14) 14
Danish (13) 13
Korean (12) 12
Turkish (10) 10
Czech (9) 9
Dutch (9) 9
Swedish (9) 9
Hungarian (7) 7
Ukrainian (6) 6
Persian (5) 5
Norwegian (4) 4
Serbian (4) 4
Slovak (4) 4
Croatian (3) 3
Hebrew (2) 2
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Archives of pharmacal research, ISSN 0253-6269, 11/2020, Volume 43, Issue 11, p. 1187
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 1, pp. 40 - 51
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 22, pp. 2061 - 2071
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 23, pp. 2433 - 2446
Journal Article
Journal of pharmaceutical and biomedical analysis, ISSN 0731-7085, 02/2019, Volume 164, pp. 698 - 705
CYP2C9 | CYP2B6 | Bupropion | NAT2 | Losartan | Dapsone | Drug metabolism | Antitubercular | HIV AIDS | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Chemistry, Analytical | Life Sciences & Biomedicine | Science & Technology | Bupropion - metabolism | Inactivation, Metabolic | Coinfection - drug therapy | Humans | Losartan - blood | Bupropion - blood | Tuberculosis - microbiology | Healthy Volunteers | Cytochrome P-450 CYP2B6 - metabolism | Young Adult | Arylamine N-Acetyltransferase | HIV Infections - microbiology | Isoenzymes - metabolism | Tuberculosis - drug therapy | Dapsone - administration & dosage | Dapsone - blood | Adult | Anti-HIV Agents - therapeutic use | Anti-HIV Agents - metabolism | Losartan - pharmacokinetics | Tandem Mass Spectrometry - methods | Cytochrome P-450 CYP2C9 - metabolism | Antitubercular Agents - therapeutic use | Bupropion - pharmacokinetics | Dapsone - pharmacokinetics | Cytochrome P-450 CYP2B6 - genetics | Isoenzymes - genetics | HIV Infections - genetics | Losartan - metabolism | Bupropion - administration & dosage | Cytochrome P-450 CYP2C9 - genetics | Dapsone - metabolism | Polymorphism, Genetic | Coinfection - microbiology | Phenotype | Coinfection - genetics | Tuberculosis - genetics | HIV Infections - drug therapy | Losartan - administration & dosage | Antitubercular Agents - metabolism | Drug Combinations | Drugs | Highly active antiretroviral therapy | Antiviral agents | Usage | Tuberculosis | Metabolites | Analysis | Cytochrome P-450 | Physiological aspects | Antitubercular agents | HIV (Viruses) | Anti-HIV agents | Index Medicus
Journal Article
Journal Article